3/9
05:01 pm
jazz
Jazz Pharmaceuticals (JAZZ) had its "overweight" rating reaffirmed by Barclays PLC.
Low
Report
Jazz Pharmaceuticals (JAZZ) had its "overweight" rating reaffirmed by Barclays PLC.
2/27
08:53 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/27
08:53 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/27
08:44 am
jazz
Jazz Pharmaceuticals (JAZZ) is now covered by Barclays PLC. They set an "overweight" rating and a $224.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals (JAZZ) is now covered by Barclays PLC. They set an "overweight" rating and a $224.00 price target on the stock.
2/27
04:38 am
jazz
Jazz Pharmaceuticals initiated with an Overweight at Barclays
Low
Report
Jazz Pharmaceuticals initiated with an Overweight at Barclays
2/27
04:38 am
jazz
Jazz Pharmaceuticals initiated with an Overweight at Barclays
Low
Report
Jazz Pharmaceuticals initiated with an Overweight at Barclays
2/25
10:51 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/25
10:51 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/25
10:43 am
jazz
Rating for JAZZ
Medium
Report
Rating for JAZZ
2/25
10:43 am
jazz
Rating for JAZZ
Medium
Report
Rating for JAZZ
2/25
09:45 am
jazz
Rating for JAZZ
Medium
Report
Rating for JAZZ
2/25
09:45 am
jazz
Rating for JAZZ
Medium
Report
Rating for JAZZ
1/12
04:40 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
1/12
04:40 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
1/8
08:02 am
jazz
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
1/8
08:02 am
jazz
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.